Asarfi Hospital Ltd

Asarfi Hospital Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Asarfi Hospital Ltd has witnessed a significant improvement in its valuation parameters, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios shifting from attractive to very attractive levels. This re-rating comes amid robust stock returns and favourable operational metrics, positioning the hospital sector player as a compelling investment opportunity in the current market environment.

Asarfi Hospital Ltd has delivered an exceptional quarterly performance for the December 2025 quarter, prompting an upgrade in its financial trend rating from ‘Very Positive’ to ‘Outstanding’. The hospital’s robust revenue growth, margin expansion, and return metrics have set new benchmarks, signalling strong operational execution and financial discipline amid a competitive healthcare sector.

Asarfi Hospital Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly financial performance, attractive valuation metrics, and a shift towards a more bullish technical outlook, signalling renewed investor confidence in this hospital sector stock.

Asarfi Hospital Limited, a micro-cap healthcare provider with a market capitalisation of ₹374.00 crores, delivered an exceptional performance in Q3 FY26, reporting consolidated net profit of ₹5.42 crores—a remarkable 102.24% surge year-on-year and 29.05% sequential growth. The Jharkhand-based hospital chain demonstrated robust operational momentum, with revenue reaching ₹46.10 crores, marking a 40.16% year-on-year expansion and 2.70% quarter-on-quarter growth.

Asarfi Hospital Ltd’s investment rating has been downgraded from Buy to Hold following a reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. Despite strong recent financial performance and market-beating returns, evolving technical signals and valuation considerations have prompted a more cautious stance from analysts.

Asarfi Hospital Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 Nov 2025. While the rating was set on that date, the analysis and financial metrics presented here reflect the company’s current position as of 27 January 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Asarfi Hospital Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Asarfi Hospital Ltd is rated 'Buy' by MarketsMOJO, a rating that was last updated on 14 Nov 2025. While this rating change took place in mid-November, the analysis and financial metrics discussed here reflect the company’s current position as of 25 December 2025, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Asarfi Hospital's market evaluation has undergone a revision reflecting nuanced changes across its financial and technical parameters, despite maintaining a robust performance trajectory in the hospital sector.

Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.221 today, marking a notable moment in the stock's recent performance and reflecting sustained momentum in the hospital sector.

Asarfi Hospital has reached an all-time high, reflecting a remarkable phase in its market journey. The stock’s recent performance underscores its strong presence in the hospital sector, with notable gains and financial metrics that highlight its current standing.

Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.193.8 today, marking a notable moment in the stock’s recent performance and momentum within the hospital sector.

Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.193.8, marking a notable achievement in its stock performance amid a mixed market environment.

Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.193.8, marking a notable achievement in its stock performance. This peak reflects the stock's strong momentum over the past year, supported by robust financial metrics and consistent quarterly results.

Asarfi Hospital has reached an all-time high stock price, reflecting its strong financial health and operational success. The company reported a significant net profit growth and record net sales for the recent quarter. Its low debt-to-EBITDA ratio further highlights its effective financial management and robust market position.